Progression to renal failure

Turkish Journal of Pediatrics

Volumn 47, Issue SUPPL., 2005, Pages 3-8

  Topaloǧlu, Rezan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Angiotensin II; Chronic kidney disease; Cytokines; Glomerular filtration rate; Growth factors; Hemodynamic factors; Progression; Proteinuria; Renal failure

Indexed keywords

ANGIOTENSIN; COLONY STIMULATING FACTOR 1; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 4; PLATELET DERIVED GROWTH FACTOR; RANTES; SIMVASTATIN; SOMATOMEDIN C; STEM CELL FACTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR; VASOPRESSIN;

ARTICLE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROTEIN RESTRICTION; PROTEINURIA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANGIOTENSINS; CHILD; CYTOKINES; DISEASE PROGRESSION; FEMALE; GROWTH SUBSTANCES; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; PRACTICE GUIDELINES; PROTEINURIA; TURKEY;

EID: 17844362175     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Yanwood SJ, Woodgett JR. Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation. Proc Natl Acad Sci USA 2001; 98: 4472-4477.
2. Fan JM, Huang XR, Ng YY, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831.
3. Sugiyama H, Kashihara N, Maeshiyama Y, et al. Regulation of survival and death of mesangial cells by extracellular matrix. Kidney Int 1998; 54: 1188-1196.
4. Isbel NB, Hill PA, Foti R, et al. Tubules are major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 2001; 60: 614-625.
5. Yang N, Wu LL, Nikoloc Paterson DJ, et al. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant 1998; 8: 1967-1974.
6. Savill JH. Regulation of glomerular cell number by apoptosis. Kidney Int 1999; 56: 1216-1222.
7. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-93.
8. Suda T, Osajima A, Tamura M, et al. Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 2001; 60: 1705-1715.
9. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 1991; 325: 1058-1062.
10. Mezzano SA, Barria M, Droguett MA, et al. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 2001; 60: 1366-1377.
11. Benigni A, Remuzzi G. How renal cytokines and growth factors contribute to renal disease progression. Am J Kidney Dis 2001; 37 (Suppl): S21-24.
12. Campese VM. Neurogenic factors and hypertension in renal disease. Kidney Int Suppl 2000; 75: S2-6.
13. Navar LG, Imig JD, Zou L, Wang CT. Intrarenal production of angiotensin II. Semin Nephrol 1997; 17: 412-422.
14. Arima S, Kohagura K, Abe M, Ito S. Mechanisms that control glomerular hemodynamics. Clin Exp Nephrol 2001; 5: 55-61.
15. Yu XQ, Wu LL, Huang XR, et al. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int 2000; 58: 1469-1480.
16. Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Physiol 2000; 278: F554-560.
17. Crook ED. Is there hope for preventing or slowing the progression of chronic renal disease? More support for the role of growth factors. Am J Kidney Dis 2001; 38: 652-657.
18. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003; 111: 1416-1421.
19. Klahr S, Morrissey J. Progression of chronic renal disease. Am J Kidney Dis 2003; 41 (Suppl): S3-7.
20. Sirin A, Emre S, Alpay H, Nayir A, Bilge I, Tanman F. Etiology of chronic renal failure in Turkish children. Pediatr Nephrol 1995; 9: 549-552.
21. Islek I, Sancak R, Van A, Gurses N. Etiology of chronic renal failure in children in the Black Sea region of Turkey. Pediatr Nephrol 1996; 10: 811.
22. Central Registry Committee. Registry of Nephrology, Dialysis and Transplantation in Turkey, Registry 2003. Istanbul: Art Ofset; September 2004: p 38.
23. Soares CM, Oliveira EA, Diniz JS, Lima EM, Vasconcelos MM, Oliveira GR. Predictive factors of progression of chronic renal insufficiency: a multivariate analysis. Pediatr Nephrol 2003; 18: 371-377.
24. Salahudeen AK. Halting progression of renal failure? consideration beyond angiotensin II inhibition. Nephrol Dial Transplant 2002; 17: 1871-1875.